Dolby Laboratories (DLB) Tops Q3 EPS by 24c

Dolby Laboratories (NYSE: DLB) reported Q3 EPS of $0.71, $0.24 better than the analyst estimate of $0.47. Revenue for the quarter came in at $286.8 million versus the consensus estimate of $278.79 million.

GUIDANCE:

Dolby Laboratories sees Q4 2021 EPS of $0.47-$0.62, versus the consensus of $0.66. Dolby Laboratories sees Q4 2021 revenue of $280-310 million, versus the consensus of $304.8 million.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Atossa Genetics (ATOS) Tops Q2 EPS by 10c
• SpyGlass Pharma (SGP) Reports Q2 Loss of $0.59